Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Improved Insulin Response and Blood Sugar Control: GLP-1s were originally used to treat type 2 diabetes
Conclusions The present study highlights the ability of rare sugar syrup components, specifically ketohexoses (D-fructose, D-allulose, D-tagatose, D-sorbose), to promote intestinal GLP-1 secretion in male murine models in a dose-dependent pattern
GLP-1 and GIP receptor agonists act in such a way that they increase the effectiveness of the other when used together
Many meta-analyses failed to adequately explore how bias in the primary studies may have influenced the overall findings, thereby undermining the robustness and credibility of the synthesized results
US$ 22.29
US$ 28.48
US$ 23.23
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 22.47
US$ 21.41
